semaglutide and inflammatory bowel disease Ozempic ulcerative colitis: Possible benefits and risks GLP-1 Use in Crohn's Disease:

Graphical abstract Access this article Similar content being viewed by others Availability of data and materials Data will be made available as per the policy of journal

All authors had full access to all of the data in the study, drafted the work or revised it critically for important intellectual content, and approved the final version of the manuscript and accept responsibility to submit for publication

These phenomena, collectively known as response shift (RS), can make patient-reported outcome measures (PROMs) scores taken at different time pointssuch as before and after surgery sometimes not directly comparable

(27 November, 2023)